The present invention relates to HCV variants, particularly variants that are resistant to a protease inhibitors such as VX-950. Also provided are methods and compositions related to the HCV variants. Further provided are methods of isolating, identifying, and characterizing multiple viral variants from a patient.

 
Web www.patentalert.com

< Kit for assessing mitochondrial toxicity

< Zinc finger proteins for DNA binding and gene regulation in plants

> TFIIS and GDOWN1 as targets for cancer therapy

> Transfection complexes
~ 00601